HCM or HGV or SCM
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
HCM’s FA Score shows that 1 FA rating(s) are green whileHGV’s FA Score has 0 green FA rating(s), and SCM’s FA Score reflects 1 green FA rating(s).
- HCM’s FA Score: 1 green, 4 red.
- HGV’s FA Score: 0 green, 5 red.
- SCM’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
HCM’s TA Score shows that 4 TA indicator(s) are bullish while HGV’s TA Score has 5 bullish TA indicator(s), and SCM’s TA Score reflects 4 bullish TA indicator(s).
- HCM’s TA Score: 4 bullish, 4 bearish.
- HGV’s TA Score: 5 bullish, 5 bearish.
- SCM’s TA Score: 4 bullish, 5 bearish.
Price Growth
HCM (@Pharmaceuticals: Other) experienced а +3.78% price change this week, while HGV (@Casinos/Gaming) price change was +5.79% , and SCM (@Investment Managers) price fluctuated -0.49% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.42%. For the same industry, the average monthly price growth was -2.50%, and the average quarterly price growth was +19109.37%.
The average weekly price growth across all stocks in the @Casinos/Gaming industry was +0.90%. For the same industry, the average monthly price growth was -3.07%, and the average quarterly price growth was +3.07%.
The average weekly price growth across all stocks in the @Investment Managers industry was +2.52%. For the same industry, the average monthly price growth was -1.68%, and the average quarterly price growth was +20.38%.
Reported Earning Dates
HCM is expected to report earnings on May 29, 2024.
HGV is expected to report earnings on Jul 25, 2024.
SCM is expected to report earnings on Jul 31, 2024.
Industries' Descriptions
@Pharmaceuticals: Other (+2.42% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
@Casinos/Gaming (+0.90% weekly)Casinos/Gaming includes companies that operate casinos, gaming services, horse racing and harness racing facilities. Think Las Vegas Sands Corp., MGM Resorts International and Wynn Resorts, Ltd. In periods of strong economic growth, consumers tend to spend on discretionary/leisure activities like gambling or games; but consumption is likely to slow down when there’s economic sluggishness.
@Investment Managers (+2.52% weekly)Investment Managers manage financial assets and other investments of clients. Management includes designing a short- or long-term strategy for buying/holding and selling of portfolio holdings. It can also include tax services and other aspects of financial planning as well. While it is perceived that the industry is faced with growing competition from robo-advisors/digital platforms and passive/ index-tracking funds, many investors still find value in actively managed in-person services that investment management companies often emphasize on. At the same time, many wealth managers are also incorporating digital initiatives/low cost options in addition to their in-person customized services. Their main sources of revenues are fees as a percentage of assets under management, in addition to a certain portion of clients’ gains from asset appreciation. BlackRock, Inc., Blackstone Group Inc and Brookfield Asset Management are some of the major investment management companies.
| HCM | HGV | SCM | |
| Capitalization | 2.88B | 4.9B | 313M |
| EBITDA | 67.3M | 840M | N/A |
| Gain YTD | 7.510 | 9.632 | 13.342 |
| P/E Ratio | 27.95 | 16.70 | 16.21 |
| Revenue | 838M | 3.98B | 21.2M |
| Total Cash | 886M | 589M | N/A |
| Total Debt | 86.1M | 4.59B | 576M |
HCM | HGV | SCM | ||
|---|---|---|---|---|
OUTLOOK RATING 1..100 | 19 | 20 | 80 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 93 Overvalued | 68 Overvalued | 4 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 57 | 35 | |
SMR RATING 1..100 | 43 | 59 | 47 | |
PRICE GROWTH RATING 1..100 | 39 | 49 | 45 | |
P/E GROWTH RATING 1..100 | 33 | 39 | 71 | |
SEASONALITY SCORE 1..100 | 50 | n/a | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
SCM's Valuation (4) in the null industry is somewhat better than the same rating for HGV (68) in the Real Estate Development industry, and is significantly better than the same rating for HCM (93) in the Pharmaceuticals Major industry. This means that SCM's stock grew somewhat faster than HGV’s and significantly faster than HCM’s over the last 12 months.
SCM's Profit vs Risk Rating (35) in the null industry is in the same range as HGV (57) in the Real Estate Development industry, and is somewhat better than the same rating for HCM (100) in the Pharmaceuticals Major industry. This means that SCM's stock grew similarly to HGV’s and somewhat faster than HCM’s over the last 12 months.
HCM's SMR Rating (43) in the Pharmaceuticals Major industry is in the same range as SCM (47) in the null industry, and is in the same range as HGV (59) in the Real Estate Development industry. This means that HCM's stock grew similarly to SCM’s and similarly to HGV’s over the last 12 months.
HCM's Price Growth Rating (39) in the Pharmaceuticals Major industry is in the same range as SCM (45) in the null industry, and is in the same range as HGV (49) in the Real Estate Development industry. This means that HCM's stock grew similarly to SCM’s and similarly to HGV’s over the last 12 months.
HCM's P/E Growth Rating (33) in the Pharmaceuticals Major industry is in the same range as HGV (39) in the Real Estate Development industry, and is somewhat better than the same rating for SCM (71) in the null industry. This means that HCM's stock grew similarly to HGV’s and somewhat faster than SCM’s over the last 12 months.
| HCM | HGV | SCM | |
|---|---|---|---|
| RSI ODDS (%) | 2 days ago 80% | 2 days ago 84% | 1 day ago 58% |
| Stochastic ODDS (%) | 2 days ago 82% | 2 days ago 80% | 1 day ago 43% |
| Momentum ODDS (%) | 2 days ago 79% | 2 days ago 74% | 1 day ago 60% |
| MACD ODDS (%) | 2 days ago 79% | 2 days ago 70% | 1 day ago 49% |
| TrendWeek ODDS (%) | 2 days ago 76% | 2 days ago 75% | 1 day ago 46% |
| TrendMonth ODDS (%) | 2 days ago 78% | 2 days ago 70% | 1 day ago 54% |
| Advances ODDS (%) | 7 days ago 78% | 2 days ago 76% | 8 days ago 53% |
| Declines ODDS (%) | 21 days ago 79% | 9 days ago 70% | 6 days ago 44% |
| BollingerBands ODDS (%) | 2 days ago 90% | 2 days ago 84% | 1 day ago 53% |
| Aroon ODDS (%) | N/A | 2 days ago 81% | 1 day ago 51% |
HGV and
Correlation & Price change
A.I.dvisor indicates that over the last year, HGV has been closely correlated with VAC. These tickers have moved in lockstep 75% of the time. This A.I.-generated data suggests there is a high statistical probability that if HGV jumps, then VAC could also see price increases.